North America Electrophysiology Market-Market Dynamics
The report details several driving factors, restraints and opportunities for the market, some of which are listed below.
Technological innovations and advancements
Increasing incidence of chronic diseases
Ease of use and interpretation of medical devices
Patient Protection and Affordable Care Act
Increasing healthcare expenditure
Rising adoption of ablation techniques
The factors constraining the growth of the market include reimbursement issues and the high cost of the medical devices.
The emerging economies, public awareness for cardiac diseases, and the huge scope for consolidation are the major opportunities in the market.
The report segments the market by types (electrophysiology monitoring devices, treatment devices) and geography (USA, Canada).
The major companies discussed in this report with their profile and relevant information from the market perspective are:
Market analysis for the North American electrophysiology market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the North American electrophysiology market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is growing and to also identify the regions that are still untapped.
1.1 Report description
1.2 Research methodology
2. Executive summary
3. Market overview
3.2 Market size and forecasts
3.3 Market dynamics
3.3.1 Market drivers
184.108.40.206 Rapidly increasing aged population
220.127.116.11 Increasing cases of cardiac diseases
18.104.22.168 Technological advancements
22.214.171.124 Patient Protection and Affordable Care Act
126.96.36.199 Increasing healthcare expenditure
188.8.131.52 Rising adoption of ablation techniques
3.3.2 Market restraints
184.108.40.206 High cost of treatment
220.127.116.11 Regulatory issues
18.104.22.168 Emerging economies
22.214.171.124 Public awareness for cardiac diseases
126.96.36.199 Huge scope for consolidation
3.3.4 Porterfive force analysis
188.8.131.52 Bargaining power of suppliers
184.108.40.206 Bargaining power of buyers
220.127.116.11 Threat of substitutes
18.104.22.168 Threat from new entrants
22.214.171.124 Competitive rivalry
4. Market segmentation
4.1 Market segmentation, by type of products
4.1.1 Electrophysiology monitoring devices
126.96.36.199 Electrocardiograph (ECG)
188.8.131.52 Electroencephalograph (EEG)
184.108.40.206 Electrocorticograph (ECOG)
220.127.116.11 Electromyograph (EMG)
18.104.22.168 Electroretinograph (ERG)
22.214.171.124 Electrooculograph (EOG)
4.1.2 Holter Monitoring Devices
126.96.36.199 X-Ray systems
188.8.131.52 Imaging and 3D mapping systems
184.108.40.206 Diagnostic electrophysiology catheters
4.1.3 Electrophysiology Treatment Devices
220.127.116.11 Implantable cardioverter defibrillators (ICDs)
18.104.22.168 Cardiac resynchronization therapy devices (CRTs)
22.214.171.124.1 Radiofrequency electrophysiology ablation catheters
126.96.36.199.2 Cryoablation electrophysiology catheters
188.8.131.52.3 Laser ablation catheters
184.108.40.206.4 Microwave ablation catheters
4.2 Market segmentation, by country
5. Competitive landscape
5.3 Product launches/developments
6. Company profiles
6.1 Biosense Webster, Inc.
6.2 St. Jude Medical, Inc.
6.3 Biotronik SE & Co. KG
6.4 Boston Scientific Corporation
6.5 Medtronic, Inc.